UPDATE: Onyx Pharmaceuticals (ONXX) Sees Activity as FDA Briefing Docs Posted

June 18, 2012 8:21 AM EDT Send to a Friend
(Updated - June 18, 2012 8:22 AM EDT)

Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) is seeing volatility as FDA briefing documents have been posted. Link

Shares last traded down fractionally to $45.28, versus Friday's close of $45.98.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Trader Talk

Add Your Comment